Video
Hear from representatives of a multi-stakeholder working group that has drafted a good practice considerations document on the responsible use of Artificial Intelligence (AI) in creating plain language trial results summaries (PLS), also known as lay summaries (LS).
The considerations document covers key areas of concern, and recommended practices in the procedural use of AI and governance elements to ensure appropriate human involvement. Technical aspects of AI development and management are not covered.
In this webinar, speakers share the background of this initiative, discuss the purpose and goal of the public comment period, and raise some of the key considerations in the document.
About the Event
Join in on the growing topic of patient data protection and policies, to inform patients on the standard of patient data collection.
Date Recorded
January 28, 2025
Meet the Panel
Ken Getz
Founder & Board Chair - CISCRP
Sudipta Chakraborty
Health Literacy / Plain Language Advocate | Associate Director - Clinical Trial Transparency
Julie Holtzople
Clinical Trial Transparency Thought Leader - Holtzople Consulting
Malgorzata Sztolszener
